latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Motley Fool
Sun, 04/28/13 - 12:13 pm
tags: Achillion, Avanir, Gilead Sciences, GSK, Medivation, Pfizer, Theravance
Seeking Alpha
Tue, 04/16/13 - 11:55 am
tags: AbbVie, Achillion, Bristol-Myers Squibb, Gilead, Idenix, Merck, sofosbuvir
TheStreet.com
Tue, 04/02/13 - 10:58 am
tags: AbbVie, Achillion, Aegerion, Amarin, Arena Pharmaceuticals, AstraZeneca, Aveo Pharmaceutical, Biogen Idec, Bristol-Myers Squibb, Delcath, Dendreon, Depomed, Gilead, GSK, Merck, NewLink Genetics, Raptor Pharmaceuticals, Rigel, Sangamo BioSciences, Sucampo, Titan Pharmaceuticals, Valeant Pharmaceuticals, Vertex Pharmaceuticals, Vivus, Zogenix
Motley Fool
Wed, 02/27/13 - 12:24 pm
Motley Fool
Wed, 01/16/13 - 1:12 pm
TheStreet.com
Wed, 01/02/13 - 1:18 pm
Seeking Alpha
Wed, 01/02/13 - 12:47 pm
Motley Fool
Sun, 12/30/12 - 1:15 pm
tags: Abbott Laboratories, Achillion, Gilead Sciences, GSK, HCV, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Motley Fool
Fri, 12/28/12 - 12:36 pm
tags: Abbott Labs, Achillion, Bristol-Myers Squibb, Gilead, GSK, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Motley Fool
Sat, 12/08/12 - 12:17 pm
tags: ACH-1625, Achillion, Gilead Sciences, hepatitis C, Medivir, sofosbuvir, TMC435
Seeking Alpha
Fri, 11/30/12 - 1:10 pm
tags: Achillion, Gilead, hepatitis C, Idenix, Medivir, Merck, Vertex Pharmaceuticals
Motley Fool
Sat, 11/24/12 - 1:01 pm
Motley Fool
Sat, 11/17/12 - 2:47 pm
Yahoo/Reuters
Wed, 11/14/12 - 1:30 pm
Motley Fool
Tue, 11/13/12 - 12:51 pm
Last 30 twitter posts
-
Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03… t.co/ZPG5EIWUJi
-
Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03:30 PM t.co/DdbVv5OJ7l #biotech
-
Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03:30 PM t.co/hwzzZHDmwh
-
Achillion presenting at UBS Healthcare Conf today at 3:30p ET live webcast here: t.co/oJ3YEQ5swu $ACHN #HCV
-
Back to the gym tomorrow after a relaxing week off in Corfu - checked out the achillion palace while there... :-) t.co/uFgfjliBpI
-
Planete - Islam, empire de la foi (Ending Preview) t.co/VifnOhpWzD #achillion via @wat_tv
-
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team $ACHN t.co/40WbynBKuF
-
Achillion appoints chief medical officer t.co/SuiWNMSg8j
-
Achillion appoints chief medical officer t.co/zjb9NboFMt
-
Achillion appoints chief medical officer t.co/yj0WQ4Ty6x
-
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations ... t.co/4q0DgpXMsm #hepatitis #HCV
-
Achillion appoints chief medical officer t.co/qDxUZz5oiL
-
Achillion appoints chief medical officer t.co/nys0M7MwK7 via @Histerius
-
Achillion appoints chief medical officer t.co/nys0M7MwK7 via @Histerius
-
Achillion Hotel Athens is one of the best reasonably priced #hotels in #Athens: t.co/Js1AhXxgB3
-
Live webcast 6pm tonight from Bank of America Healthcare Conf link avail here t.co/oJ3YEQ5swu $ACHN #HCV
-
Welcome Dr. David Apelian and Kevin Kucharski to Achillion t.co/oJ3YEQ5swu $ACHN #HCV
-
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations ... t.co/4q0DgpXMsm #hepatitis #HCV
-
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team t.co/6eNAKJMEPo
-
$ACHN adds K.Kucharski former Pharmasset;Dr.Appelian as CMO;Expands Clinical OpsTeam -t.co/30c7bUYEbw
-
$Achillion Appoints Dr. D.Apelian as Chief Medical Officer and Expands Clinical Operations Team - Yahoo! Finance t.co/30c7bUYEbw
-
$ACHN: Achillion Pharma appoints David Apelian as Chief Medical Officer and expands clinical operations team t.co/nPYZb7viv7
-
$ACHN took almost a year to replace CMO, Elizabeth Olek: t.co/L7J9Dmf6VB
-
RT @Benzinga: Achillion Names Dr. David Apelian CMO t.co/fYHeEwLmi6 $ACHN
-
Achillion Names Dr. David Apelian CMO t.co/fYHeEwLmi6 $ACHN
-
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team: [GlobeNews... t.co/xL8m1Izmar
-
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team t.co/Z7CYC9DtV8 #biotech
-
#daytrading Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clin... t.co/LyQvQVgpIK #pennystocks #money
-
$ACHN Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Cl.. t.co/sSN15NHp0d
Latest Health Message Board Posts
... this month. Read more: http://www.businessweek.com/news/2012-08-28/achillion-takeover-looms-as-hepatitis-treatments-fail-real-m-and-a ---------------------------------------------------------------------------------------------------- Please use careful ...
Posted by:
Cheesegrater
at
2013-03-20 05:00:00
on
medhelp.org
... /ACHN_News_2012_8_7_General.pdf I found a poster on this trial that went out in for EASL in April 2012 http://www.achillion.com/PL/pdf/ACHN_ACH-1625_PH2_EASL12.pdf Some of the numbers in Segment 2, table 3 do not agree with the numbers mentioned ...
Posted by:
veteranB
at
2012-10-22 05:00:00
on
medhelp.org
... 2013, which means filing would be postponed until mid-2014. In addition to Gilead and BMS, Roche AG, Johnson & Johnson, Achillion Pharmaceuticals Inc., Abbott and Idenix Pharmaceuticals Inc. all have candidates they are developing for interferon-free HCV ...
Posted by:
veteranB
at
2012-10-20 05:00:00
on
medhelp.org
... of chronic hepatitis C (HCV). ACH-3102 is a pan-genotypic second-generation NS5A inhibitor against HCV that was discovered by Achillion and is currently being evaluated in a Phase 1 clinical trial. Fast Track designation was requested for ACH-3102 for its ...
Posted by:
rpooo
at
2012-10-06 05:00:00
on
medhelp.org
This was a brand new concept Vertex and Merck were coming out with .Because they have led the way with this class of drug,.it shouldn't take near as long for Tibotec(TMC435) and Achillion to get their same class drugs (protease) to market . JMO Will
Posted by:
Cheesegrater
at
2012-08-07 05:00:00
on
medhelp.org
Hhere is a list of Pharma stocks that are volatile as of this morning. Abbott,Achillion,Astra Zeneneca, Merck, Pharmasett,,Tibotec,Boehringer Ingelheim, BMS,Gilead,Anady"s,Pfizer,,Vertex.... All of the above currently are in the HCV future ...
Posted by:
orphanedhawk
at
2012-07-31 05:00:00
on
medhelp.org
... board for Genentech, Vertex, Merck, Gilead, BMS, Abbott, Phenomix, Tibotec, Pharmasset, Pfizer, Conatus, 3RT, Novartis, J&J, Achillion, and Regulus; and receiving grants or contracts from Genentech, Vertex, Gilead, BMS, Abbott, Quest, Conatus, Tibotec ...
Posted by:
rivll
at
2012-05-17 05:00:00
on
medhelp.org
... attracted others than the Big Three already mentioned. Companies testing therapies, either alone or together, include Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Merck (NYSE: MRK) and Vertex Pharmaceuticals ...
Posted by:
willbb
at
2012-01-07 06:00:00
on
medhelp.org
... attracted others than the Big Three already mentioned. Companies testing therapies, either alone or together, include Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Merck (NYSE: MRK) and Vertex Pharmaceuticals ...
Posted by:
willbb
at
2011-10-10 05:00:00
on
medhelp.org
... an interesting article in Seeking Alpha. It seems somebody thinks the new HCV drugs will be effective against HIV. http://seekingalpha.com/article/1272281-achillion-a-tiny-biopharmaceutical-stock-with-tremendous-potential?source=yahoo comments? Cheese
Posted by:
mikesimon
at
2010-11-10 06:00:00
on
medhelp.org